| Filed On | Filing |
|---|---|
| 30 Mar 2026 |
Form 4: Jenkins David A, Director
Granted 40,000 Options (Right to Buy) |
| 30 Mar 2026 |
Form 4: Anderson Philip J, Chief Financial Officer
Granted 40,000 Options (Right to Buy) |
| 30 Mar 2026 |
Form 4: Arno Andrew, Director
Granted 40,000 Options (Right to Buy) |
| 30 Mar 2026 |
Form 4: Caruso James Joseph, Director
Granted 40,000 Options (Right to Buy) |
| 30 Mar 2026 |
Form 4: Colombatto Martin J, Director
Granted 40,000 Options (Right to Buy) |
| 18 Feb 2026 |
Form 4: Jenkins David A, Director
Acquired 9,489.488 Series J Preferred Stock (Other Transaction) |
| 20 Jan 2026 |
Form 4: Jenkins David A, Chairman of the Board and CEO
Acquired 340,000 Series M Common Stock Purchase Warrant (Other Transaction) ($530K) |
| 08 Dec 2025 |
Form 4: Caruso James Joseph, Director
Received 41 shares by conversion |
| 08 Dec 2025 |
Form 4: Jenkins David A, Chairman of the Board and CEO
Received 43,006 shares by conversion |
| 14 Aug 2025 |
Form 4: Arno Andrew, Director
Granted 50,000 Options (Right to Buy) |
| 14 Aug 2025 |
Form 4: Caruso James Joseph, Director
Granted 50,000 Options (Right to Buy) |
| 14 Aug 2025 |
Form 4: Colombatto Martin J, Director
Granted 50,000 Options (Right to Buy) |
| 14 Aug 2025 |
Form 4: Jenkins David A, Director
Granted 500,000 Options (Right to Buy) |
| 03 Mar 2025 |
Form 4: Anderson Philip J, Chief Financial Officer
Granted 500,000 Option (Right to Buy) |
| 31 Jan 2025 |
Form 4: Colombatto Martin J, Director
Sold 3 shares ($1.2) · Granted 100,000 Stock Option |
| 31 Jan 2025 |
Form 4: Jenkins David A, Chairman of the Board and CEO
Granted 450,000 Stock Option |
| 31 Jan 2025 |
Form 4: Jacques Marie-Claude, Chief Commercial Officer
Granted 125,000 Stock Option |
| 31 Jan 2025 |
Form 4: Caruso James Joseph, Director
Granted 100,000 Stock Option |
| 31 Jan 2025 |
Form 4: Arno Andrew, Director
Granted 100,000 Stock Option |
| 03 May 2024 |
Form 4: Jacques Marie-Claude, Chief Commercial Officer
Granted 250,000 Option (Right to Buy) |
Loading...